Clinical Trial Update: The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study evaluating the OLANI long-acting naltrexone implant in healthy volunteers to characterize pharmacokinetics and assess s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• OLANI (naltrexone)

Snippet

Sponsor: Go Medical Industries Pty Ltd | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED | Results posted: 2022-08-01